Results 191 to 200 of about 12,023 (208)

Detection of NTRK1/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing

Endocrine Pathology, 2020
Harn-Shen Chen, Jen-Fan Hang, Fiac
exaly  

Calcified chondroid mesenchymal neoplasms with FN1-receptor tyrosine kinase gene fusions including FGFR2, FGFR1, MERTK, NTRK1, and TEK: a molecular and clinicopathologic analysis

Modern Pathology, 2021
Yajuan J Liu, Jose G Mantilla, Robert W Ricciotti   +2 more
exaly  

The pancreatic cancer genome revisited

Nature Reviews Gastroenterology and Hepatology, 2021
Akimasa Hayashi, Jungeui Hong, Christine A Iacobuzio-Donahue   +2 more
exaly  

NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types

British Journal of Cancer, 2021
Christian C Rolfo, Alexander Drilon, Afshin Dowlati   +2 more
exaly  

NTRK fusion-positive cancers and TRK inhibitor therapy

Nature Reviews Clinical Oncology, 2018
Emiliano Cocco, Maurizio Scaltriti, Alexander Drilon   +2 more
exaly  

NTRK1

2006
openaire   +1 more source

From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer

Nature Reviews Clinical Oncology, 2019
Christopher Nevala-Plagemann, Manuel Hidalgo, Ignacio Garrido-Laguna   +2 more
exaly  

Evidence of NTRK1 Fusion as Resistance Mechanism to EGFR TKI in EGFR+ NSCLC: Results From a Large-Scale Survey of NTRK1 Fusions in Chinese Patients With Lung Cancer

Clinical Lung Cancer, 2020
Qiuxiang Ou, Xue Wu, Misako Nagasaka
exaly  

A novel group of spindle cell tumors defined by S100 and CD34 co‐expression shows recurrent fusions involving RAF1, BRAF, and NTRK1/2 genes

Genes Chromosomes and Cancer, 2018
Albert J H Suurmeijer, Brendan C Dickson, Yun-Shao Sung   +2 more
exaly  

Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance

Nature Reviews Clinical Oncology, 2017
Alison M Schram, Matthew T Chang, Philip Jonsson   +2 more
exaly